MedTrace Logo

A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

NCT00144066 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2005-09-02

No results posted yet for this study

Summary

A randomized phase III trial of platinum-based chemotherapy alone versus platinum-based chemotherapy followed by maintenance therapy with gefitinib in patients with stage IIIB/IV NSCLC.

Conditions

Interventions

DRUG

platinum-based chemotherapy alone (up to six cycles)

DRUG

platinum-based chemotherapy followed by maintenance therapy with gefitinib

Sponsors & Collaborators

  • West Japan Thoracic Oncology Group

    lead OTHER

Principal Investigators

  • Toyoaki Hida, MD, PhD · West Japan Thoracic Onoclogy Group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00144066 on ClinicalTrials.gov